Global /South Korea /Healthcare /Drug Manufacturers - General /012790

Sinil Pharmaceutical Co., Ltd.

012790

• KRX: 012790 • Delayed

6,300KRW -0.6%

4.15 USD

As of 17 June 2026, Sinil Pharmaceutical Co., Ltd. has a market cap of $47.48M USD, ranking #31026 globally and #1798 in South Korea. It ranks #2803 in the Healthcare sector, and #980 in the Drug Manufacturers - General industry.

Global Rank

31026

Country Rank

1798

Sector Rank

2803

Industry Rank

980

Key Stats

Market Cap

$47.48MUSD

71.67B KRW

Enterprise Value

$21.57MUSD

32.74B KRW

Revenue (TTM)

$53.37MUSD

80.56B KRW

EBITDA (TTM)

$8.81MUSD

13.38B KRW

Net Income (TTM)

$4.99MUSD

7.53B KRW

EBITDA Margin

17%

Profit Margin

9.3%

PE Ratio

9.5

PS Ratio

0.9

PB Ratio

0.5

EV/EBITDA

2.4

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Mi-Keun Jung open_in_new

Employees

287

Founded

1971

Website

sinilpharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.6%	0.3%	5.3%	6.2%	4.3%	4.4%	-2%	-18%	-57%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	012790 신일제약(주) ISIN: KR7012790002 Shares Out.: Shares Outstanding: 11.56M¹ Shares Float: 7.306M² TV: TradingView: KRX: 012790 SA: Stock Analysis: KRX: 012790 YF: Yahoo Finance: 012790.KS GF: Google Finance: KRX: 012790 BA: Barron's: 012790 MS: Morningstar: XKRX: 012790	6,300 KRW	TV: TradingView: KRX: 012790 SA: Stock Analysis: KRX: 012790 YF: Yahoo Finance: 012790.KS GF: Google Finance: KRX: 012790 BA: Barron's: 012790 MS: Morningstar: XKRX: 012790

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Sinil Pharmaceutical Co., Ltd.

Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In addition, it is involved in the real estate rental services. The company was founded in 1971 and is headquartered in Chungju-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.22B 13.91T KRW 19K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.83B 10.3T KRW 14K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.28B 7.97T KRW 11K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$5.0B 7.55T KRW 10K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.58B 6.92T KRW 10K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.48B 6.76T KRW 9K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 2M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 1M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 759K%	97.4	United States
Roche Holding AG SIX: RO	$322.73B 256.25B CHF 680K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.3B 215.59B GBP 609K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.68B 218.9B CHF 580K%	20.5	Switzerland

chevron_leftBack